Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
Jaume Folch, Dmitry S. Petrov, Miren Ettcheto, et al.
Neural Plasticity (2016) Vol. 2016, pp. 1-15
Open Access | Times Cited: 257

Showing 1-25 of 257 citing articles:

Cross Mark Policy

(2022)
Open Access | Times Cited: 1336
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline, Maíra A. Bicca, Kirsten L. Viola, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S567-S610
Open Access | Times Cited: 699
Neuroinflammation pathways: a general review
Tara Shabab, Ramin Khanabdali, Soheil Zorofchian Moghadamtousi, et al.
International Journal of Neuroscience (2016) Vol. 127, Iss. 7, pp. 624-633
Closed Access | Times Cited: 518
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, et al.
Journal of Controlled Release (2018) Vol. 281, pp. 139-177
Closed Access | Times Cited: 489
Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
Darshpreet Kaur, Vivek Sharma, Rahul Deshmukh
Inflammopharmacology (2019) Vol. 27, Iss. 4, pp. 663-677
Closed Access | Times Cited: 365
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Jiqing Cao, Jianwei Hou, Jing Ping, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 237
Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
Luke Cassidy, Francesca Fernandez, Joel B. Johnson, et al.
Complementary Therapies in Medicine (2019) Vol. 49, pp. 102294-102294
Closed Access | Times Cited: 227
Therapies for Prevention and Treatment of Alzheimer’s Disease
Jesus Mendiola-Precoma, Laura C. Berumen, Karla Padilla, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-17
Open Access | Times Cited: 225
Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
Gabriela Dumitrița Stanciu, Andrei Luca, Răzvan Nicolae Rusu, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 40-40
Open Access | Times Cited: 222
Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
Stéphanie Andrade, Maria João Ramalho, Joana A. Loureiro, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2313-2313
Open Access | Times Cited: 201
Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
Teeba Athar, Khalid Al Balushi, Shah Alam Khan
Molecular Biology Reports (2021) Vol. 48, Iss. 7, pp. 5629-5645
Open Access | Times Cited: 182
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, et al.
Journal of Controlled Release (2020) Vol. 321, pp. 372-415
Closed Access | Times Cited: 178
Neuroprotective Herbs for the Management of Alzheimer’s Disease
Julie Gregory, Yasaswi Vengalasetti, Dale E. Bredesen, et al.
Biomolecules (2021) Vol. 11, Iss. 4, pp. 543-543
Open Access | Times Cited: 162
Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer’s Disease
Manish Kumar, Nitin Bansal
Molecular Neurobiology (2021) Vol. 59, Iss. 1, pp. 354-385
Closed Access | Times Cited: 122
WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective
Kakarla Ramakrishna, Lakshmi Vineela Nalla, Naresh Dumala, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 89-89
Open Access | Times Cited: 93
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Young‐Ju Jang, Seong-Jun Kang, Hyun Su Park, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3
A Perspective – can copper complexes be developed as a novel class of therapeutics?
Mohamed Wehbe, Ada W.Y. Leung, Michael J. Abrams, et al.
Dalton Transactions (2017) Vol. 46, Iss. 33, pp. 10758-10773
Closed Access | Times Cited: 161
Insulin-Degrading Enzyme in the Fight against Alzheimer’s Disease
Igor V. Kurochkin, Enrico Guarnera, Igor N. Berezovsky
Trends in Pharmacological Sciences (2017) Vol. 39, Iss. 1, pp. 49-58
Closed Access | Times Cited: 158
Protein aggregation and neurodegenerative diseases: From theory to therapy
Vijay Kumar, Neha Sami, Tara Kashav, et al.
European Journal of Medicinal Chemistry (2016) Vol. 124, pp. 1105-1120
Closed Access | Times Cited: 143
Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease
Kushal Kumar, Ashwani Kumar, Richard M. Keegan, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 98, pp. 297-307
Closed Access | Times Cited: 135
Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease
Étienne Croteau, Christian‐Alexandre Castellano, Marie Anne Richard, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. 2, pp. 551-561
Closed Access | Times Cited: 121
Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?
Yuan Dong, Xiaoheng Li, Jinbo Cheng, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 558-558
Open Access | Times Cited: 118
Effects of Acupuncture Therapy on MCI Patients Using Functional Near-Infrared Spectroscopy
Usman Ghafoor, Jun‐Hwan Lee, Keum‐Shik Hong, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 95
Memantine‐Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Elena Sánchez‐López, María Antonia Egea, Benjamin Davis, et al.
Small (2017) Vol. 14, Iss. 2
Open Access | Times Cited: 94
The Neurovascular Unit Dysfunction in Alzheimer’s Disease
Luis O. Soto-Rojas, Mar Pacheco‐Herrero, Paola A. Martínez-Gómez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2022-2022
Open Access | Times Cited: 94
Page 1 - Next Page

Scroll to top